Arecor Therapeutics PLC on Tuesday announced a new partnership in the growing field of diabetes and obesity treatments.
The West Sussex, England-based biopharmaceutical firm will work with drug.
IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi lse.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lse.co.uk Daily Mail and Mail on Sunday newspapers.
Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Notes announcement from Inhibrx Inc and Sanofi SA that both companies have agreed Sanofi will acquires all.